Literature DB >> 9236592

Salvage neck dissection for cervical recurrence of nasopharyngeal carcinoma.

K L Yen1, L P Hsu, T S Sheen, Y L Chang, M H Hsu.   

Abstract

OBJECTIVE: To evaluate the effectiveness of salvage neck dissection as part of a multidisciplinary treatment approach in persistent or recurrent metastatic nasopharyngeal carcinoma, after failure of initial radiotherapy at the regional site.
DESIGN: A retrospective study of 31 patients treated during a 14-year period from March 1981 through May 1995, with a maximum follow-up of 152 months. Factors evaluated include patients' sex, age, and initial stage of tumor, mobility and number of nodal recurrences, surgical and pathological findings, and postoperative irradiation.
SETTING: Academic tertiary referral center. PATIENTS: Twenty-six men and 5 women were studied; one patient had neck dissection to both sides of the neck on separate occasions, for a total of 32 operations. All patients had pathologically proved nasopharyngeal carcinoma and had been previously treated at the primary site and both sides of the neck with definitive radiotherapy. INTERVENTION: Patients underwent a radical, modified radical, or level I-sparing radical neck dissection. MAIN OUTCOME MEASURE: Surgical morbidity, time to recurrence at the regional site, and survival time.
RESULTS: Clinically, there was a disease predilection of 81% at levels II and V. Surgical morbidity was minimal. Regional control was achieved in 20 (65%) of the patients, and the overall 5-year survival was 67%. Tumor involvement of the posterior triangle musculature and spinal accessory nerve was associated with failure to control neck disease. Extracapsular nodal extension correlated with a poor survival outcome.
CONCLUSION: Control of regional disease by salvage neck dissection when radiotherapy has failed is both safe and effective in properly selected patients.

Entities:  

Mesh:

Year:  1997        PMID: 9236592     DOI: 10.1001/archotol.1997.01900070069011

Source DB:  PubMed          Journal:  Arch Otolaryngol Head Neck Surg        ISSN: 0886-4470


  9 in total

1.  Is it necessary to perform radical neck dissection as a salvage procedure for persistent or recurrent neck disease after chemoradiotherapy in patients with nasopharyngeal cancer?

Authors:  Avi Khafif; Alfio Ferlito; Robert P Takes; K Thomas Robbins
Journal:  Eur Arch Otorhinolaryngol       Date:  2010-03-30       Impact factor: 2.503

2.  [Treatment results of nasopharyngeal carcinoma in adults].

Authors:  M Jakob; M Manz; S Herberhold; A Schröck; A O H Gerstner; H Schüller; K W G Eichhorn
Journal:  HNO       Date:  2012-12       Impact factor: 1.284

3.  Prognostic significance of extracapsular spread in isolated neck recurrences in head and neck squamous cell carcinoma patients.

Authors:  Xavier León; Antoni Rigó; Nuria Farré; Montserrat López; Jacinto García; Julia de Juan; Miquel Quer
Journal:  Eur Arch Otorhinolaryngol       Date:  2016-08-10       Impact factor: 2.503

4.  Outcome of surgical management of persistent or recurrent neck mass in patients with nasopharyngeal carcinoma after radiotherapy.

Authors:  Cheng-Yu Lin; Sen-Tien Tsai; Ying-Tai Jin; Ming-Wei Yang; I-Chun Yeh; Jenn-Ren Hsiao
Journal:  Eur Arch Otorhinolaryngol       Date:  2007-12-07       Impact factor: 2.503

5.  Salvage surgery for neck residue or recurrence of nasopharyngeal carcinoma: a 10-year experience.

Authors:  Ling Zhang; Yong-xue Zhu; Yu Wang; Cai-ping Huang; Yi Wu; Qing-hai Ji
Journal:  Ann Surg Oncol       Date:  2010-08-25       Impact factor: 5.344

6.  Salvage surgery for neck residue or recurrence of nasopharyngeal carcinoma after primary radiotherapy: options of surgical methods and regions.

Authors:  Sheng-ye Wang; Jian-lin Lou; Jianxiang Chen; Su-zhan Zhang; Liang Guo
Journal:  World J Surg Oncol       Date:  2016-03-25       Impact factor: 2.754

7.  The prognosis of neck residue nasopharyngeal carcinoma (NPC) patients: results from a case-cohort study.

Authors:  Sai-Lan Liu; Lin-Quan Tang; Qiu-Yan Chen; Huan-Xin Lin; Qi Yang; Qian Zhu; Wen Wen; Shan-Shan Guo; Li-Ting Liu; Yang Li; Hao-Jun Xie; Qing-Nan Tang; Xue-Song Sun; Yu-Jing Liang; Xiao-Yun Li; Jin-Jie Yan; Chao Lin; Xiao-Wen Lan; Hai-Qiang Mai; Ling Guo
Journal:  J Cancer       Date:  2018-04-19       Impact factor: 4.207

Review 8.  Progression of understanding for the role of Epstein-Barr virus and management of nasopharyngeal carcinoma.

Authors:  Yosuke Nakanishi; Naohiro Wakisaka; Satoru Kondo; Kazuhira Endo; Hisashi Sugimoto; Miyako Hatano; Takayoshi Ueno; Kazuya Ishikawa; Tomokazu Yoshizaki
Journal:  Cancer Metastasis Rev       Date:  2017-09       Impact factor: 9.264

9.  The diagnostic and prognostic values of plasma Epstein-Barr virus DNA for residual cervical lymphadenopathy in nasopharyngeal carcinoma patients: a retrospective study.

Authors:  Sai-Lan Liu; Xue-Song Sun; Xiao-Yun Li; Lin-Quan Tang; Qiu-Yan Chen; Huan-Xin Lin; Yu-Jing Liang; Jin-Jie Yan; Chao Lin; Shan-Shan Guo; Li-Ting Liu; Yang Li; Hao-Jun Xie; Qing-Nan Tang; Hu Liang; Ling Guo; Hai-Qiang Mai
Journal:  Cancer Commun (Lond)       Date:  2019-03-29
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.